- Home
- ADPT vs CCEC Comparison
ADPT vs CCEC Comparison
Compare ADPT & CCEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADPT
- CCEC
- Stock Information
- Founded
- ADPT 2009
- CCEC 2007
- Country
- ADPT United States
- CCEC Greece
- Employees
- ADPT N/A
- CCEC N/A
- Industry
- ADPT Biotechnology: Biological Products (No Diagnostic Substances)
- CCEC Marine Transportation
- Sector
- ADPT Health Care
- CCEC Consumer Discretionary
- Exchange
- ADPT Nasdaq
- CCEC Nasdaq
- Market Cap
- ADPT 929.8M
- CCEC 1.1B
- IPO Year
- ADPT 2019
- CCEC 2007
- Fundamental
- Price
- ADPT $6.81
- CCEC $18.75
- Analyst Decision
- ADPT Buy
- CCEC Buy
- Analyst Count
- ADPT 4
- CCEC 1
- Target Price
- ADPT $6.75
- CCEC $22.00
- AVG Volume (30 Days)
- ADPT 1.3M
- CCEC 16.3K
- Earning Date
- ADPT 02-12-2025
- CCEC 01-31-2025
- Dividend Yield
- ADPT N/A
- CCEC 3.20%
- EPS Growth
- ADPT N/A
- CCEC N/A
- EPS
- ADPT N/A
- CCEC 0.85
- Revenue
- ADPT $177,282,000.00
- CCEC $447,305,000.00
- Revenue This Year
- ADPT $6.48
- CCEC $17.05
- Revenue Next Year
- ADPT $18.72
- CCEC $5.68
- P/E Ratio
- ADPT N/A
- CCEC $75.99
- Revenue Growth
- ADPT N/A
- CCEC 29.66
- 52 Week Low
- ADPT $2.28
- CCEC $14.45
- 52 Week High
- ADPT $7.46
- CCEC $20.26
- Technical
- Relative Strength Index (RSI)
- ADPT 54.92
- CCEC N/A
- Support Level
- ADPT $5.98
- CCEC N/A
- Resistance Level
- ADPT $7.28
- CCEC N/A
- Average True Range (ATR)
- ADPT 0.54
- CCEC 0.00
- MACD
- ADPT -0.00
- CCEC 0.00
- Stochastic Oscillator
- ADPT 58.06
- CCEC 0.00
About ADPT Adaptive Biotechnologies Corporation
Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).
About CCEC Capital Clean Energy Carriers Corp. Common Share
Capital Clean Energy Carriers Corp is an international shipping company. It is the leading platform of gas carriage solutions with a focus on the energy transition. The company owns 20 high-specification vessels, including 12 latest-generation LNG carriers (LNG/Cs) and eight legacy Neo-Panamax container vessels.